Aashka Hospitals Ltd - 543346 - Results - Financial Results For The Year Ending March 31, 2022
Audited Financial Result for the Half Year and Year ended on March 31, 202218-01-2023
Aashka Hospitals Ltd - 543346 - Results - Financial Results For The Year Ending March 31, 2022
Audited Financial Result for the Half Year and Year ended on March 31, 2022Aashka Hospitals Ltd - 543346 - Board Meeting Outcome for Board Meeting Outcome - Financial Results
Board has inter alia considered and approved Audited Financial Result for the Half Year and Year ended on March 31, 2022, as recommended by the Audit CommitteeAashka Hospitals Ltd - 543346 - Board Meeting Intimation for Board To Consider And Approve The Financial Results For The Quarter And Year Ended On March 31, 2022
Aashka Hospitals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/01/2023 ,inter alia, to consider and approve Board fo Directors to consider and approve the financial results for the quarter and year ended on March 31, 2022Aashka Hospitals Ltd - 543346 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2022Aashka Hospitals Ltd - 543346 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2022Aashka Hospitals Ltd - 543346 - Board Meeting Outcome for Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Appointment Of Company Secretary, Chief Financial Officer And Independent Director
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 ('LODR Regulations'), the meeting of Board of Directors of the Company held today i.e. October 7, 2022 at 05:00 pm and concluded at 05:30 pm, and has inter alia considered and approved the following on the recommendation of the Nomination & Remuneration Committee: 1) Appointment of Mr. Umang Shah (DIN: 09735002), as the Additional Independent Director for the tenure of 5 (five) years w.e.f. October 7, 2022. 2) Appointment of Mr. Mayank Agarwal, as the Company Secretary and Compliance Officer of the Company w.e.f. October 7, 2022. 3) Appointment of Mr. Lokesh Khandelval as the Chief Financial Officer (CFO) of the Company w.e.f. October 7, 2022. Further the details required under Regulation 30 of the LODR Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 are given in Annexure - I.Aashka Hospitals Ltd - 543346 - Announcement Under Regulation 30 (LODR) - Appointment Of CFO
Appointment of Mr. Lokesh Khandelval as the Chief Financial Officer (CFO) of the Company w.e.f. October 7, 2022Aashka Hospitals Ltd - 543346 - Appointment of Company Secretary and Compliance Officer
Appointment of Mr. Mayank Agarwal, as the Company Secretary and Compliance Officer of the Company w.e.f. October 7, 2022Aashka Hospitals Ltd - 543346 - Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Mr. Umang Shah (DIN: 09735002), as the Additional Independent Director for the tenure of 5 (five) years w.e.f. October 7, 2022Aashka Hospitals Ltd - 543346 - Closure of Trading Window
In compliance with the amended SEBI (Prohibition of Insider Trading) Regulations, 2015, we hereby inform you that the Trading Window (for sale/purchase and dealing in the Company''s Equity Shares) will remain closed from Saturday, October 01, 2022 for all designated persons and their immediate relatives. The trading window shall open after 48 hours of announcement of Financial Results of the Company for the half year ended September 30, 2022.